Table 1. Probes depleted in bicalutamide-treated LNCaP cells.

shRNA target gene	Description	Probes scored*	log2 (Bic/Veh)**	p value
STRN3	Striatin, calmodulin binding protein 3, cell cycle protein	2	−1.527 −1.008	0.0037 0.0073
STRADA	STE20-related kinase adaptor alpha	1	−1.197	0.0003
TTK	Ser/Thr/Tyr kinase, cell cycle regulated	3	−1.014 −1.018 −0.991	0.0039 0.0040 0.0073
MAST3	Microtubule associated Ser/Thr kinase 3	1	−0.901	0.0009
PSMC1	Proteasome 26S subunit ATPase 1	2	−0.900 −0.880	0.0048 0.0060
CIT	Citron, Rho-interacting, Ser/Thr kinase 21	2	−0.802 −0.815	9.12E-05 0.0001
RABGAP1	GTPase-activating protein of RAB6A, microtubule/centrosome function	1	−0.791	0.0035
PRKACG	Gamma form of Protein Kinase A catalytic subunit	1	−0.758	0.0043
IGF1R	Insulin-like growth factor 1 receptor	2	−0.716 −0.681	0.0047 0.0091
TSSK2	Testes-specific serine kinase 2	1	−0.666	0.0045
VEGFβ	Vascular endothelial growth factor beta	2	−0.660 −0.594	0.0015 0.0026
MAPKAPK5	Mitogen-activated protein kinase-activated protein kinase 5	1	−0.645	0.0095
ABL2	V-abl Abelson murine leukemia viral oncogene homolog 2, tyrosine kinase	1	−0.621	0.0047
PLK2	Polo-like kinase 2, Ser/Thr kinase	2	−0.598 −0.584	0.0045 0.0085
AKT1	Ser/Thr kinase	1	−0.594	0.0041

^*Number of probes that had a log2 value ≤−0.58.

^**Bic, bicalutamide; Veh, vehicle.